Full-length human surfactant protein A inhibits influenza A virus infection of A549 lung epithelial cells: A recombinant form containing neck and lectin domains promotes infectivity
Open Access
- 1 May 2019
- journal article
- research article
- Published by Elsevier in Immunobiology
- Vol. 224 (3) , 408-418
Abstract
No abstract availableKeywords
Funding Information
- KACST (14-MED258-20)
- the RAC of the KFSHRC, Riyadh, Saudi Arabia (2150031)
This publication has 34 references indexed in Scilit:
- Pandemic influenza A/H1N1 virus infection and TNF, LTA, IL1B, IL6, IL8, and CCLpolymorphisms in Mexican population: a case–control studyBMC Infectious Diseases, 2012
- Interleukin-6 Is a Potential Biomarker for Severe Pandemic H1N1 Influenza A InfectionPLOS ONE, 2012
- The pathogenesis of influenza virus infections: the contributions of virus and host factorsCurrent Opinion in Immunology, 2011
- Clinical aspects and cytokine response in severe H1N1 influenza A virus infectionCritical Care, 2010
- Pandemic H1N1 Influenza A Viruses Are Resistant to the Antiviral Activities of Innate Immune Proteins of the Collectin and Pentraxin SuperfamiliesThe Journal of Immunology, 2010
- Host adaptive immunity deficiency in severe pandemic influenzaCritical Care, 2010
- Susceptibility of mice genetically deficient in SP-A or SP-D gene to Invasive Pulmonary AspergillosisMolecular Immunology, 2010
- Immune dysregulation in severe influenzaJournal of Leukocyte Biology, 2009
- Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein DRespiratory Research, 2008
- Influenza Virus Matrix Protein Is the Major Driving Force in Virus BuddingJournal of Virology, 2000